CanSino Biologics Inc. (6185.HK)
HKD 30.5
(0.83%)
HKD 30.5
(0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -916.25 Million | -1.88 Billion | 2.01 Billion | -469.38 Million | -170.18 Million | -123.63 Million |
| Net Income | -1.97 Billion | -1.18 Billion | 1.9 Billion | -407.04 Million | -156.76 Million | -138.28 Million |
| Depreciation & Amortization | 269.05 Million | 196.36 Million | 88.54 Million | 31.81 Million | 22.47 Million | 12.01 Million |
| Deferred income taxes | - | - | -43.58 Million | -7.79 Million | -128 Thousand | -12.33 Million |
| Stock-based compensation | 9.54 Million | 10.08 Million | 9.8 Million | 17.51 Million | 21.51 Million | 15.78 Million |
| Change in working capital | -156.95 Million | -1.47 Billion | 84.3 Million | -100.77 Million | -12.81 Million | 378 Thousand |
| Other non-cash items | -75.76 Million | 568.91 Million | -31.59 Million | -3.1 Million | -44.47 Million | -1.19 Million |
| Investing Cash Flow | -441.62 Million | -1.19 Billion | -2.53 Billion | -182.71 Million | -797.77 Million | 117.62 Million |
| Investments in PPE | -610.47 Million | -1.07 Billion | -1.2 Billion | -270.77 Million | -116.94 Million | -160.67 Million |
| Acquisitions | -110.03 Million | -3.25 Million | -64.87 Million | -886 Thousand | -6.89 Million | 11.25 Million |
| Investment purchases | -8.09 Billion | -12.36 Billion | -8.47 Billion | -6.28 Billion | -1.66 Billion | -1.44 Billion |
| Sales/Maturities of investments | 8.36 Billion | 12.21 Billion | 7.12 Billion | 6.25 Billion | 967.86 Million | 1.72 Billion |
| Other Investing Activities | 8.02 Million | 35.68 Million | 94.02 Million | 120.34 Million | 22.85 Million | -9.28 Million |
| Financing Cash Flow | -7.58 Million | 854.6 Million | 1.55 Billion | 4.94 Billion | 1.09 Billion | 45.05 Million |
| Debt repayment | -69.28 Million | -1.36 Billion | -160 Million | -22.49 Million | -7.3 Million | -41.66 Million |
| Dividends payments | -3.62 Million | -193.93 Million | -14.09 Million | -6.69 Million | -8.78 Million | -7.59 Million |
| Common Stock Repurchased | - | -150.16 Million | - | - | 7.3 Million | - |
| Common Stock Issuance | - | - | - | 4.98 Billion | 1.12 Billion | 17.48 Million |
| Other Financing Activities | 16.98 Million | 2.56 Billion | 1.73 Billion | 4.97 Billion | -28.16 Million | 35.16 Million |
| Accounts receivables | 265.96 Million | -495.79 Million | -419.93 Million | -107.76 Million | -8.59 Million | -7.95 Million |
| Accounts payables | - | 495.79 Million | 419.93 Million | 107.76 Million | 8.59 Million | - |
| Inventory | -214.35 Million | -604.01 Million | -706.39 Million | -144.15 Million | -8.08 Million | -6.87 Million |
| Other working capital | 11.2 Million | -874.93 Million | 790.7 Million | 43.38 Million | -4.73 Million | 7.24 Million |
| Cash at beginning of period | 3.39 Billion | 5.45 Billion | 4.44 Billion | 201.97 Million | 57.38 Million | 18.24 Million |
| Cash at end of period | 2.04 Billion | 3.39 Billion | 5.45 Billion | 4.44 Billion | 201.97 Million | 57.38 Million |
| Capital Expenditure | -610.47 Million | -1.07 Billion | -1.2 Billion | -270.77 Million | -116.94 Million | -160.67 Million |
| Effect of forex changes on cash | 20.28 Million | 160.76 Million | -33.78 Million | -27.36 Million | 21.72 Million | 92 Thousand |
| Net cash flow / Change in cash | -1.34 Billion | -2.06 Billion | 1 Billion | 4.24 Billion | 144.59 Million | 39.13 Million |
| Free Cash Flow | -1.52 Billion | -2.96 Billion | 811.42 Million | -740.16 Million | -287.13 Million | -284.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -55.27 Million | -170.09 Million | -1.97 Billion | -497.7 Million | -143.6 Million | -701.88 Million |
| Depreciation & Amortization | 112.8 Million | - | 269.05 Million | 263.24 Million | -122.24 Million | 122.24 Million |
| Deferred income taxes | - | - | - | - | -197.21 Million | 213.71 Million |
| Stock-based compensation | 2.43 Million | - | 9.54 Million | 9.54 Million | -5.67 Million | 5.67 Million |
| Change in working capital | -12.97 Million | - | -156.95 Million | 60.62 Million | 219.39 Million | -232.98 Million |
| Other non-cash items | -153.03 Million | 61.9 Million | -75.76 Million | 5.03 Million | 254.27 Million | 414.93 Million |
| Investing Cash Flow | -272.8 Million | 275.01 Million | -441.62 Million | -229.84 Million | -143.77 Million | 104.01 Million |
| Investments in PPE | -128.63 Million | -134.41 Million | -610.47 Million | -163.2 Million | -128.63 Million | -103.39 Million |
| Acquisitions | -30.75 Million | - | -110.03 Million | -109.65 Million | 95.61 Million | -96 Million |
| Investment purchases | -3.38 Billion | -2.14 Billion | -8.09 Billion | -2.82 Billion | -1.57 Billion | -1.55 Billion |
| Sales/Maturities of investments | 3.8 Billion | 2.03 Billion | 8.36 Billion | 1.79 Billion | 2.53 Billion | 1.31 Billion |
| Other Investing Activities | -156.05 Million | 520.92 Million | 8.02 Million | 1.07 Billion | -1.07 Billion | 542.45 Million |
| Financing Cash Flow | -260.68 Million | 147.37 Million | -7.58 Million | 123.73 Million | 90.81 Million | -211.66 Million |
| Debt repayment | -240.91 Million | -166.07 Million | -69.28 Million | -158.02 Million | -180.37 Million | -209.93 Million |
| Dividends payments | -16.84 Million | -16.78 Million | -3.62 Million | -33.9 Million | -33.9 Million | -16.61 Million |
| Common Stock Repurchased | - | -16.78 Million | - | 57.89 Million | -57.89 Million | 23.05 Million |
| Common Stock Issuance | - | - | - | - | 35.87 Million | - |
| Other Financing Activities | 1.9 Million | -1.9 Million | 16.98 Million | 31.54 Million | 327.12 Million | 21.88 Million |
| Accounts receivables | 41.37 Million | - | 265.96 Million | 265.96 Million | 171.23 Million | -171.23 Million |
| Accounts payables | - | - | - | - | -13.58 Million | - |
| Inventory | -54.34 Million | - | -214.35 Million | -216.54 Million | 48.15 Million | -48.15 Million |
| Other working capital | - | - | 11.2 Million | 11.2 Million | 13.58 Million | -13.58 Million |
| Cash at beginning of period | 2.37 Billion | 2.04 Billion | 3.39 Billion | 2.35 Billion | 2.38 Billion | 2.84 Billion |
| Cash at end of period | 1.72 Billion | 2.37 Billion | 2.04 Billion | 2.04 Billion | 2.35 Billion | 2.38 Billion |
| Capital Expenditure | -128.63 Million | -134.41 Million | -610.47 Million | -163.2 Million | -128.63 Million | -103.39 Million |
| Effect of forex changes on cash | -2.23 Million | 14.61 Million | 20.28 Million | -31.5 Million | 14.97 Million | 56.3 Million |
| Net cash flow / Change in cash | -653.65 Million | 328.8 Million | -1.34 Billion | -304.89 Million | -33.05 Million | -459.84 Million |
| Free Cash Flow | -234.67 Million | -242.61 Million | -1.52 Billion | -322.45 Million | -123.7 Million | -495.39 Million |
SRU-UN
PYRAMID
UTHR
NOU
KETL
KIN2